EFS of the CardioMech MVRS
Start Date
7/27/2021
Completion Date
9/1/2031
Summary
Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
Detailed Description
The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+), symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary heart team.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
CardioMech MVRS
Conditions
Locations
Cardiovascular Institute of Los Robles Health System
Thousand Oaks, California 91360
United States
Northwestern University
Evanston, Illinois 60208
United States
Ascension St. Francis via Christi
Wichita, Kansas 67226
United States
Mayo Clinic
Rochester, Minnesota 55902
United States
CentraCare Heart & Vascular Center
Saint Cloud, Minnesota 56303
United States
NYU Langone
New York, New York 10016
United States
Atrium Health Sanger Heart and Vascular Institute
Charlotte, North Carolina 28204
United States
The Christ Hospital
Cincinnati, Ohio 45219
United States
Cleveland Clinic
Cleveland, Ohio 44195
United States
Ascension St. Thomas West
Nashville, Tennessee 37205
United States
Baylor Scott & White, The Heart Hospital
Plano, Texas 75093
United States
Intermountain Medical Center
Murray, Utah 84107
United States